Advertisement

Topics

Clinical Trials About "Medical News Today Test gives accurate prognosis breast" RSS

03:49 EST 11th December 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Medical News Today Test gives accurate prognosis breast" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Medical News Today Test gives accurate prognosis breast" on BioPortfolio

We have published hundreds of Medical News Today Test gives accurate prognosis breast news stories on BioPortfolio along with dozens of Medical News Today Test gives accurate prognosis breast Clinical Trials and PubMed Articles about Medical News Today Test gives accurate prognosis breast for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medical News Today Test gives accurate prognosis breast Companies in our database. You can also find out about relevant Medical News Today Test gives accurate prognosis breast Drugs and Medications on this site too.

Showing "Medical News Today Test gives accurate prognosis breast" Clinical Trials 1–25 of 26,000+

Relevant

Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by English-speaking Patients

The main objective of this study is to compare the interpretation of health news items reporting results of randomized controlled trials (RCTs) with or without spin (i.e., distortion of research results). The news items which reported those studies evaluating the treatment effect, having highest number of spin in the headline and text and received high online public attention will be selected. Spin will be deleted and will rewrite the news items without spin. This sample of new...


Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Patients

The main objective of this study is to compare the interpretation of health news items reporting results of randomized controlled trials (RCTs) with or without spin (i.e., distortion of research results). The news items which reported those studies evaluating the treatment effect, having highest number of spin in the headline and text and received high online public attention will be selected. Spin will be deleted and will rewrite the news items without spin. This sample of new...

Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Population

The main objective of this study is to compare the interpretation of health news items reporting results of randomized controlled trials (RCTs) with or without spin (i.e., distortion of research results). The news items which reported those studies evaluating the treatment effect, having highest number of spin in the headline and text and received high online public attention will be selected. Spin will be deleted and will rewrite the news items without spin. This sample of new...


Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by English-speaking Population

The main objective of this study is to compare the interpretation of health news items reporting results of randomized controlled trials (RCTs) with or without spin (i.e., distortion of research results). The news items which reported those studies evaluating the treatment effect, having highest number of spin in the headline and text and received high online public attention will be selected. Spin will be deleted and will rewrite the news items without spin. This sample of new...

DNA Chip Based Prognosis of Lung Cancer

The purpose of the study is to determine whether a DNA chip, designed by Medical Prognosis Institute (MPI), can provide an accurate prognosis for survival of NSCLC (adeno-, squamous and large cell lung cancer).

Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities

This is a study looking at advanced imaging such as PET/CT and MRI to see if they can provide a more accurate assessment of the patient with dense breasts or difficult to interpret mammograms. In addition, the ability to determine whether one or the other is more accurate or whether both together would be appropriate in this clinical situation, may be able to be measured. The MRI studies are very sensitive for detection of breast histopathology but less specific in diffe...

The Role of NEWS on Intensive Care Discharges

This study aims to determine the ability of the NEWS at tertiary intensive care unit discharges to predict the development of clinical deterioration.

Cardiac Toxicity in Medical Treatment of Breast Cancer

This study will describe the epidemiology including prognosis of heart failure related to treatment with anthracycline and trastuzumab for breast cancer. In a prospective study Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer patients scheduled for trastuzumab treatment at Odense University Hospital, will be offered advanced echocardiographic examination, test of bio-markers and genetic markers for the purpose of investigating if early identification of ...

Comparison of First Sense Breast Exam® to the University of Toledo Mammography and Biopsy Results

First Sense Medical®, LLC is a medical device company developing a novel breast cancer screening tester called the First Sense Breast Exam® Tester. This radiation free tester is being developed to produce data which will be analyzed by Therma-Scan Reference Laboratory. When the tester is in production, a test will take approximately 7 minutes and will be performed in a doctor's office.

Molecular Breast Imaging (MBI) in Patients With Atypical Ductal Hyperplasia (ADH), Atypical Lobular Hyperplasia (ALH), or Lobular Carcinoma In Situ (LCIS)

This study is being done to test the ability of an investigational breast imaging camera to distinguish between cancerous tumors in the breast and tumors in the breast which are benign (not cancerous) but increase the risk of developing breast cancer. A preliminary study with this camera suggests that it is at least as accurate as a standard mammogram in the detection of small breast cancers.

Women Informed to Screen Depending on Measures of Risk

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family history or genetics (except BRCA carriers) are recommended to have annual mammograms starting at age 40. Mammograms benefit women by detecting cancers early when they are easier to treat, but they are not perfect. Recent news stories have discussed some of the potential harms: large numbers of positive results that cause stressful recalls f...

Evaluation Study of Web-based Resource for Youth

This study will evaluate DigiKnowIt News, a web-based resource to educate youth about pediatric clinical research. Youth will be randomly assigned to one of three groups (1. Intervention Version A; 2) Intervention Version B; 3) Wait-list control).

The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer

In patients with breast cancer who undergo neoadjuvant chemotherapy or neoadjuvant hormone therapy molecular breast imaging (MBI) is an accurate test for assessing response rate to neoadjuvant therapy.

Angiogenesis in Early Breast Cancer for Prognosis Prediction

This study will investigate the association of angiogenesis in breast cancer measured by magnetic resonance imaging and biomarkers with long-term prognosis of patients.

Living Conditions and Breast Cancer

The main objective of this study is to estimate of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS: stages 1 or 2 the "good prognosis "versus the witnesses: stage 3 or 4 bad prognosis).

Informed Implementation of Breast Density Reporting

1. To develop brief informational videos, Vidscrips, that can be sent to women following their mammogram to provide personalized information that integrates breast density with overall breast cancer risk, and provides information about additional care recommendations and talking tips for conversations with the health care providers. 2. To test the effectiveness of this tool in a trial of 300 women undergoing mammography. The investigators hypothesize that...

Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience

This study aims to define the association between psychological resilience and biomolecular signatures in cancer patients and to relate psychological resilience to prognosis, as this could potentially open up a novel avenue of therapeutic interventions, medical as well as psychosocial.

Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer

The trial population of this study is composed of women aged more than 18, who have developed a newly node-negative (or pN1mi), Estrogen Receptor (ER)-positive, Her2-negative invasive breast cancer with uncertainty on the indication of adjuvant chemotherapy using standard assessments. Obtaining material for test is at no risk as done from the surgery material. Tumor molecular EndoPredict (EP)clin analysis will allow to obtain information on the expression of 8 breast can...

Weight Gain Prevention for Breast Cancer Survivors

Primary Objectives: - To test the feasibility of a randomized controlled trial of a weight gain prevention program for breast cancer survivors that combines exercise and dietary changes during treatment. Feasibility will be evaluated by examining data on recruitment rate, attendance at intervention sessions, drop-out rates in both study conditions, assessment completion rates, and participant feedback. - To test the effect of a weight gain pre...

Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms

This study evaluates a second review of ultrasound images of breast lesions using an interactive "deep learning" (or artificial intelligence) program developed by Samsung Medical Imaging, to see if this artificial intelligence will help the Radiologist make more accurate diagnoses.

Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older

POC Medical Systems has developed a Point of Care system for the screening of breast cancer in the general population. Via a proprietary algorithm, the MammoAlert™ is expected to determine breast cancer's risk level for a subject by identifying the presence in plasma of known biomarkers. The present study aims to determine the Sensitivity and Specificity of the test in plasma samples of subjects of whom the status vis-à-vis breast cancer is known.

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Multiple neoadjuvant endocrine trials demonstrate that women with good prognosis tumors can be identified. A new standard of care needs to be defined for elderly women with good prognosis ER+ tumors, since these women may benefit from endocrine therapy alone to treat their cancer without compromising local and distant control. The investigators hypothesize that endocrine therapy alone provides adequate local and systemic control of breast cancer in a subpopulation of women 75 ...

Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis

Primary purpose : To develop a method to automatically extract and structure the information included in numerous medical records from breast cancer patients. Secondary purpose : With this procedure we can analyze the content of ten thousand anonymized textual medical records. This information should enable us to explore many subjects, such as: - The impact of certain therapeutic procedures - The characteristics of sub-groups of patients -...

Difference in the Estimation of Prognosis

The primary objective is to identify the difference in the estimation of prognosis of advanced cancer patients between medical oncologists and palliative care physicians.

Identification of the Sick Patient in the ED

This non-interventional study will test scoring systems used to identify high risk patients when they are triaged upon presentation in the Emergency Department (ED) in a single hospital in the Northwest of England between May and July 2017.E The study will involve collecting data only from a cohort of 500 consecutive patients who arrive at the ED. Patients who have a traumatic, purely obstetric or purely psychiatric condition will be excluded. Patients will be triaged as is ro...


More From BioPortfolio on "Medical News Today Test gives accurate prognosis breast"

Advertisement
Quick Search
Advertisement
Advertisement